Journalartikel

Inflammation and bone metabolism


AutorenlisteNeumann, E.; Mueller-Ladner, U.; Frommer, K. W.

Jahr der Veröffentlichung2014

Seiten342-34+

ZeitschriftZeitschrift für Rheumatologie

Bandnummer73

Heftnummer4

ISSN0340-1855

eISSN1435-1250

DOI Linkhttps://doi.org/10.1007/s00393-013-1288-5

VerlagSpringer


Abstract
A finely balanced relationship between bone resorption and bone formation is characteristic for a healthy bone metabolism. Osteoblasts are responsible for bone formation and osteoclasts for bone resorption. In general inflammatory and in particular chronic inflammatory processes influence osteoblast and osteoclast function directly or via indirect mechanisms. Bone metabolism can be influenced by the interaction of cytokines, hormones and growth factors with bone cells. A central factor involved in bone metabolism is the receptor activator of nuclear factor-kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system, which is influenced by different inflammatory processes. Usually, (chronic) inflammation results in increased bone loss. The molecular mechanisms and pathophysiological pathways of bone metabolism under the influence of inflammation are summarized in this review.



Zitierstile

Harvard-ZitierstilNeumann, E., Mueller-Ladner, U. and Frommer, K. (2014) Inflammation and bone metabolism, Zeitschrift für Rheumatologie, 73(4), pp. 342-34+. https://doi.org/10.1007/s00393-013-1288-5

APA-ZitierstilNeumann, E., Mueller-Ladner, U., & Frommer, K. (2014). Inflammation and bone metabolism. Zeitschrift für Rheumatologie. 73(4), 342-34+. https://doi.org/10.1007/s00393-013-1288-5



Schlagwörter


Bone resorptioninfliximabJOINT DAMAGEMETHOTREXATEOSTEOBLASTSOSTEOCLASTOGENESISOSTEOCLASTSOSTEOPROTEGERINRANKLReceptor activator of NF-kappa B ligandRHEUMATOID-ARTHRITIS


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-02-04 um 02:15